Biocure Technology Inc.

As of June 30, 2026, Biocure Technology Inc. carries a market capitalization of 1.11M, placing it among publicly traded companies globally. Its enterprise value stands at 1.17M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Biocure Technology Inc. has 20.21M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Biocure Technology Inc. maintains a current ratio of 0.05, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -9.88, indicating conservative leverage, while an interest coverage ratio of -31.11 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -230.88, reflecting losses generated across the asset base.

As of the close on July 29, 2026, Biocure Technology Inc.'s stock has gained approximately 120.00% over the past 52 weeks. The 50-day moving average sits at 0.06, while the 200-day moving average is 0.24.

Over the twelve months ended June 30, 2026, Biocure Technology Inc. generated - - in revenue and converted that into -2.32M in net income, yielding earnings per share of -0.14. EBITDA reached -346,700.00, while operating income came in at -346,700.00.

As of June 30, 2026, Biocure Technology Inc. holds 3,550.00 in cash and equivalents against 63,847.00 in total debt, resulting in a net debt position of 60,297.00. Total book value stands at -646,284.00, with working capital of -646,286.00 providing operational flexibility.

Biocure Technology Inc.'s most recent stock split took place on November 11, 2024 with a 9:1 split ratio.

As of June 30, 2026, Biocure Technology Inc. has an Altman Z-Score of -1,170.04, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.